Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders

被引:17
|
作者
Pinna, Federica [1 ]
Deriu, Luca [1 ]
Lepori, Tiziana [1 ]
Maccioni, Raffaela [1 ]
Milia, Paola [1 ]
Sarritzu, Elisabetta [1 ]
Tusconi, Massimo [1 ]
Carpiniello, Bernardo [1 ]
机构
[1] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Sect Psychiat, I-09127 Cagliari, Italy
关键词
Remission; Symptomatology; Functioning; Quality of life; Subjective well-being; Schizophrenia; Schizoaffective disorders; QUALITY-OF-LIFE; SYMPTOMATIC REMISSION; FUNCTIONAL REMISSION; CRITERIA; SCALE; RELIABILITY; ADHERENCE; PSYCHOSIS;
D O I
10.1016/j.psychres.2013.08.022
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
To date, few studies have reported analytical data relating to clinical remission, functional remission and subjective experience. The present study aimed to investigate these aspects in a sample of chronic outpatients. Methods: 112 schizophrenic or schizoaffective outpatients (Males=60; Females=52; mean age 43.5 +/- 9.42 yr) were evaluated with regard to symptomatology (SCID-I; PANSS, CGI-SCH scales), functioning (PSP scale), subjective wellbeing (SWN-K scale) and Quality of Life (WHO-QoL-Bref scale). Results: 50% of patients were found to be in remission. Significantly higher scores at PANNS, CGI-SCH, PSP, but not at SWN and WHO-QoL, were found among remitted patients; a relevant proportion of remitted subjects continued to manifest a moderate level of symptoms (score >3) both at PANSS (35% of cases) and CGI-SCH (29% of cases), significant functional impairment (total score <70) at PSP (68% of cases), and a lesser degree of wellbeing (total score <80) at SWN-K (34% of cases). Conclusion: patients in whom clinical remission was confirmed may display persisting symptoms, relevant areas of functional impairment and a decreased sense of wellbeing. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:739 / 744
页数:6
相关论文
共 50 条
  • [31] Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders
    Federica Pinna
    Luca Deriu
    Enrica Diana
    Valeria Perra
    Rachele Pisu Randaccio
    Lucia Sanna
    Massimo Tusconi
    Bernardo Carpiniello
    [J]. Annals of General Psychiatry, 14
  • [32] Are schizoaffective patients just good prognostic schizophrenia patients? A longitudinal study
    Harrow, M
    Herbener, ES
    Kaplan, KJ
    Goldberg, JF
    Martin, EM
    Silverstein, ML
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 8 - 9
  • [33] COGNITIVE FUNCTIONS IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER PATIENTS: A COMPARATIVE STUDY
    Mondragon-Maya, Alejandra
    Ramos-Mastache, Daniela
    Yanez-Tellez, Guillermina
    Saracco-Alvarez, Ricardo
    [J]. SCHIZOPHRENIA BULLETIN, 2017, 43 : S124 - S125
  • [34] Relative Perceptions of the Needs of Inpatients with Schizophrenia and Schizoaffective Disorders
    Grinshpoon, Alexander
    Friger, Michael
    Orev, Eyal
    Shvarts, Shifra
    Kaplan, Ze'ev
    Abramowitz, Moshe Z.
    Ponizovsky, Alexander M.
    [J]. ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES, 2008, 45 (03): : 201 - 209
  • [35] Assessment of basic symptoms in schizophrenia, schizoaffective and bipolar disorders
    Ricca, V
    Galassi, F
    LaMalfa, G
    Mannucci, E
    Barciulli, E
    Cabras, PL
    [J]. PSYCHOPATHOLOGY, 1997, 30 (01) : 53 - 58
  • [36] Neurocognition in Early-Onset Schizophrenia and Schizoaffective Disorders
    Hooper, Stephen R.
    Giuliano, Anthony J.
    Youngstrom, Eric A.
    Breiger, David
    Sikich, Linmarie
    Frazier, Jean A.
    Findling, Robert L.
    McClellan, Jon
    Hamer, Robert M.
    Vitiello, Benedetto
    Lieberman, Jeffrey A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2010, 49 (01): : 52 - 60
  • [37] Impairments in executive functioning in patients with remitted and non-remitted schizophrenia
    Yun, Da Young
    Hwang, Samuel Suk-Hyun
    Kim, Yeni
    Lee, Young Ho
    Kim, Yong-Sik
    Jung, Hee Yeon
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (04): : 1148 - 1154
  • [38] FACTORS RELATED TO EMPLOYABILITY OF OUTPATIENTS WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS
    Martini, Larissa C.
    Petreche, Beatriz
    Lima, Fernanda Vieira
    Barbosa, Patricia
    Silva, Ana Olivia
    Moraes, Gisela
    Ferreira, Carlos Antonio
    Attux, Cecilia
    Bressan, Rodrigo
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 153 : S345 - S345
  • [39] Electrocardiographic abnormalities and psychotropic polypharmacy in schizophrenia and schizoaffective disorders
    Tirupati, Srinivasan
    Gulati, Sachal
    [J]. AUSTRALASIAN PSYCHIATRY, 2022, 30 (02) : 243 - 246
  • [40] Effect of therapy with atypical antipsychotic drugs on prolactin concentration in patients with schizophrenia and schizoaffective disorders
    L. N. Gorobets
    [J]. Bulletin of Experimental Biology and Medicine, 2005, 140 : 714 - 715